183 related articles for article (PubMed ID: 29470490)
1. Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera.
Das S; Angsantikul P; Le C; Bao D; Miyamoto Y; Gao W; Zhang L; Eckmann L
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006266. PubMed ID: 29470490
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide.
Merritt EA; Sarfaty S; van den Akker F; L'Hoir C; Martial JA; Hol WG
Protein Sci; 1994 Feb; 3(2):166-75. PubMed ID: 8003954
[TBL] [Abstract][Full Text] [Related]
3. Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.
Yu RK; Usuki S; Itokazu Y; Wu HC
Glycobiology; 2016 Jan; 26(1):63-73. PubMed ID: 26405107
[TBL] [Abstract][Full Text] [Related]
4. Cholera: pathophysiology and emerging therapeutic targets.
Muanprasat C; Chatsudthipong V
Future Med Chem; 2013 May; 5(7):781-98. PubMed ID: 23651092
[TBL] [Abstract][Full Text] [Related]
5. Binding of Vibrio cholera toxin and the heat-labile enterotoxin of Escherichia coli to GM1, derivatives of GM1, and nonlipid oligosaccharide polyvalent ligands.
Schengrund CL; Ringler NJ
J Biol Chem; 1989 Aug; 264(22):13233-7. PubMed ID: 2666416
[TBL] [Abstract][Full Text] [Related]
6. Modifications of cholera toxin subunit B binding to human large intestinal epithelium. An immunohistochemical study.
Kirkeby S; Lynge Pedersen AM
Microb Pathog; 2018 Nov; 124():332-336. PubMed ID: 30145256
[TBL] [Abstract][Full Text] [Related]
7. Microbes and microbial Toxins: paradigms for microbial-mucosal toxins. V. Cholera: invasion of the intestinal epithelial barrier by a stably folded protein toxin.
Lencer WI
Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G781-6. PubMed ID: 11292584
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of cholera toxin in complex with fucosylated receptors point to importance of secondary binding site.
Heim JB; Hodnik V; Heggelund JE; Anderluh G; Krengel U
Sci Rep; 2019 Aug; 9(1):12243. PubMed ID: 31439922
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of cholera toxin by Rosaceae family plant extracts.
Komiazyk M; Palczewska M; Sitkiewicz I; Pikula S; Groves P
BMC Complement Altern Med; 2019 Jun; 19(1):140. PubMed ID: 31221152
[TBL] [Abstract][Full Text] [Related]
10. Towards new cholera prophylactics and treatment: Crystal structures of bacterial enterotoxins in complex with GM1 mimics.
Heggelund JE; Mackenzie A; Martinsen T; Heim JB; Cheshev P; Bernardi A; Krengel U
Sci Rep; 2017 May; 7(1):2326. PubMed ID: 28539625
[TBL] [Abstract][Full Text] [Related]
11. Membrane traffic and the cellular uptake of cholera toxin.
Lencer WI; Hirst TR; Holmes RK
Biochim Biophys Acta; 1999 Jul; 1450(3):177-90. PubMed ID: 10395933
[TBL] [Abstract][Full Text] [Related]
12. A 'catch-and-release' receptor for the cholera toxin.
Mahon CS; Wildsmith GC; Haksar D; de Poel E; Beekman JM; Pieters RJ; Webb ME; Turnbull WB
Faraday Discuss; 2019 Oct; 219(0):112-127. PubMed ID: 31313796
[TBL] [Abstract][Full Text] [Related]
13. Bile and unsaturated fatty acids inhibit the binding of cholera toxin and Escherichia coli heat-labile enterotoxin to GM1 receptor.
Chatterjee A; Chowdhury R
Antimicrob Agents Chemother; 2008 Jan; 52(1):220-4. PubMed ID: 17954701
[TBL] [Abstract][Full Text] [Related]
14. Picomolar inhibition of cholera toxin by a pentavalent ganglioside GM1os-calix[5]arene.
Garcia-Hartjes J; Bernardi S; Weijers CA; Wennekes T; Gilbert M; Sansone F; Casnati A; Zuilhof H
Org Biomol Chem; 2013 Jul; 11(26):4340-9. PubMed ID: 23689250
[TBL] [Abstract][Full Text] [Related]
15. Microgels Sopping Up Toxins-GM1a-Functionalized Microgels as Scavengers for Cholera Toxin.
Boesveld S; Jans A; Rommel D; Bartneck M; Möller M; Elling L; Trautwein C; Strnad P; Kuehne AJC
ACS Appl Mater Interfaces; 2019 Jul; 11(28):25017-25023. PubMed ID: 31265226
[No Abstract] [Full Text] [Related]
16. Toxin receptors and their pathogenetic significance.
Gyr K
Acta Histochem Suppl; 1984; 29():95-102. PubMed ID: 6425929
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent derivatives of ganglioside GM1 function as receptors for cholera toxin.
Spiegel S
Biochemistry; 1985 Oct; 24(21):5947-52. PubMed ID: 3002428
[TBL] [Abstract][Full Text] [Related]
18. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system.
Blanco LP; DiRita VJ
Cell Microbiol; 2006 Jun; 8(6):982-98. PubMed ID: 16681839
[TBL] [Abstract][Full Text] [Related]
19. The β-subunit of cholera toxin has a high affinity for ganglioside GM1 embedded into solid supported lipid membranes with a lipid raft-like composition.
Margheri G; D'Agostino R; Trigari S; Sottini S; Del Rosso M
Lipids; 2014 Feb; 49(2):203-6. PubMed ID: 24122042
[TBL] [Abstract][Full Text] [Related]
20. Liposome fluidity alters interactions between the ganglioside GM1 and cholera toxin B subunit.
Terrell J; Yadava P; Castro C; Hughes J
J Liposome Res; 2008; 18(1):21-9. PubMed ID: 18348069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
